TABLE 1.
Subfertility parameters of men and women in the study population of the virtual embryoscope study
| Normal weight menN = 86 | Overweight menN = 94 | Obese menN = 41 | p‐Value | |
|---|---|---|---|---|
| Indications for subfertility treatment: n (%) | ||||
| Male factor | 29 (33.7%) | 34 (36.2%) | 11 (26.8%) | 0.17 |
| Combined male‐female | 10 (11.6%) | 18 (19.6%) | 14 (34.1%) | |
| Female factor | 32 (37.2%) | 33 (35.1%) | 10 (24.4%) | |
| Unexplained | 15 (17.4%) | 9 (9.6%) | 6 (14.6%) | |
|
Male factors: n (%) |
N = 39 (29 males and 10 combined females–males) | N = 52 (34 males and 18 combined females–males) | N = 25 (11 males and 14 combined females–males) | 0.35 |
| OA(T) | 38 | 49 | 25 | |
| An‐ and retrograde ejaculation | 1 | 3 | 0 | |
|
Female factors: n (%) |
N = 42 (32 females and 10 combined females–males) | N = 51 (33 females and 18 combined females–males) | N = 24 (10 females and 14 combined females–males) | 0.51 |
| Tuba factor | 7 | 10 | 6 | |
| Ovulation disorder | 18 | 23 | 8 | |
| Endometriosis | 11 | 13 | 9 | |
| Others | 6 | 5 | 1 | |
| Oocytes aspired | 9 [5–14] | 8 [5.5–13] | 8 [5–11.5] | 0.59 |
| Ovarian stimulation: n (%) | 0.47 | |||
| GnRH‐Agonist | 22 (25.6%) | 17 (18.1%) | 14 (34.1%) | |
| GnRH‐Antagonist | 64 (76.1%) | 77 (81.9%) | 27 (65.9%) | |
|
Fertilization type n (%) |
0.35 | |||
| IVF | 46 (53.5%) | 42 (44.7%) | 14 (34.1%) | |
| ICSI | 40 (46.5%) | 52 (55.3%) | 27 (65.9%) | |
| TMSC (×106), IQR | 25.8 [2.7–110.3] | 12.1 [0.2–85.8] | 8.0 [0.6–55.4] | 0.09 |
Abbreviations: GnRH, gonadotropin‐releasing hormone; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilization; IQR, interquartile range; OAT; oligoasthenoteratozoospermia, TMSC, total motile sperm count.